Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascularization, Choroidal”

342 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 342 results

Testing effectiveness (Phase 2)Study completedNCT00376701
What this trial is testing

Combination Therapy for Age-Related Macular Degeneration.

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Testing effectiveness (Phase 2)WithdrawnNCT00696592
What this trial is testing

Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University of Padova
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Testing effectiveness (Phase 2)Ended earlyNCT02214628
What this trial is testing

Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 101
Large-scale testing (Phase 3)Not Yet RecruitingNCT07496567
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Not applicableUnknownNCT01360151
What this trial is testing

Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Seoul St. Mary's Hospital 16
Testing effectiveness (Phase 2)UnknownNCT00100087
What this trial is testing

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Theragenics Corporation 30
Testing effectiveness (Phase 2)WithdrawnNCT03374670
What this trial is testing

ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation
Not applicableStudy completedNCT05229237
What this trial is testing

Conbercept for Polypoidal Choroidal Vasculopathy（START Study）

Who this might be right for
Polypoidal Choroidal VasculopathyConbercept
Peking Union Medical College Hospital 500
Very early researchNot Yet RecruitingNCT06879301
What this trial is testing

Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients

Who this might be right for
Diabetic Macular Edema (DME)Retinal Vein Occlusion (RVO)Myopic Choroidal Neovascularisation
Tanta University 60
Testing effectiveness (Phase 2)UnknownNCT01790893
What this trial is testing

Treatment for Presumed Ocular Histoplasmosis

Who this might be right for
Ocular Histoplasmosis
John Kitchens, MD 40
Post-approval studies (Phase 4)Study completedNCT01863199
What this trial is testing

Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Retinal Consultants of Arizona 60
Not applicableWithdrawnNCT01336907
What this trial is testing

Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Notal Vision Ltd.
Post-approval studies (Phase 4)Study completedNCT03042871
What this trial is testing

Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Zhongshan Ophthalmic Center, Sun Yat-sen University 54
Not applicableUnknownNCT04488887
What this trial is testing

OCTA Metrics Repeatability and Reproducibility in Different Disorders

Who this might be right for
Diabetic RetinopathyMyopiaChoroidal Neovascularization+1 more
Tanta University 80
Not applicableActive Not RecruitingNCT04439708
What this trial is testing

Biomarkers and Choroidal Neovascularization

Who this might be right for
Choroidal NeovascularizationMineralocorticoid Excess
Institut National de la Santé Et de la Recherche Médicale, France 250
Not applicableUnknownNCT00568191
What this trial is testing

Stratus Versus Cirrus OCT in AMD

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 100
Testing effectiveness (Phase 2)Study completedNCT01157715
What this trial is testing

A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 122
Not applicableEnded earlyNCT00272766
What this trial is testing

Macugen for Histoplasmosis

Who this might be right for
Ocular HistoplasmosisChoroidal Neovascularization
Barnes Retina Institute 24
Load More Results